Press Room
Pharma Pipeline Transparency Makes It Hard To Hide Negative Clinical Trials
02/26/2013
Over the last decade, pharmaceutical companies began to become very transparent about their R&D productivity by periodically publishing the contents of their R&D pipelines on the company websites.
Dropout from treatment, lack of nutrition lower cure rate of paediatric cancer
02/25/2013
As opposed to an 80 per cent cure rate for paediatric cancer in western countries, the five-year survival rate is only around 60 per cent in Puducherry, according to data available with the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in-hospital registry.
‘Survivor Spotlight’ features stories of hope
02/24/2013
Cancer touches everyone - whether it be through a family member or friend, or if you suffer from the disease yourself. Chances are good that everyone knows at least one person with cancer. Since the disease is so far-reaching, sharing positive stories of the triumphs and courage of those fighting the disease became crucial.
Activist Ignites A Movement For Patients Through Art And Story
02/23/2013
The conference is far from typical. There’s no foundation underwriting it, no public relations firm managing it, and no hotel ballroom. Instead there is a scholarship system, donated food, and an educational center that still features the old-time river town set that once welcomed casino-goers.
IBN Creates Unlimited Source of Human Kidney Cells
02/22/2013
Researchers at the Institute of Bioengineering and Nanotechnology (IBN) have successfully generated human kidney cells from human embryonic stem cells in vitro.
Gene mutation findings classify renal cell carcinoma
02/21/2013
Researchers have identified mutation-defined subtypes of clear cell renal cell carcinoma (ccRCC) that have distinct clinical outcomes.
New Compound Holds High Promise in Battling Kidney Cancer
02/21/2013
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer.
Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma?
02/19/2013
OBJECTIVE: To compare outcomes of metastatic renal cell carcinoma (mRCC) patients who underwent primary cytoreductive nephrectomy (CRN), followed by adjuvant sunitinib therapy, vs those who underwent primary sunitinib therapy before planned CRN.
High Death Risk Tied to mTOR Drugs in Cancer
02/18/2013
Fatal adverse events occurred more than twice as often in cancer patients treated with mTOR inhibitors compared with control therapies, a review of multiple clinical trials showed.
PSU’s THON Raises $12.3 Million, Shattering Record
02/18/2013
Students and families who journey through the emotional weekend experience many highs and lows. For the Deckman’s of Mountain Top. It’s a year to celebrate. They said THON has been a huge help for their family as their son Caleb battled kidney cancer.
News Feed| Powered by NeonCRM |